Repurposing lansoprazole to alleviate metabolic syndrome via PHOSPHO1 inhibition

MLA

Yingting Wu, et al. “Repurposing Lansoprazole to Alleviate Metabolic Syndrome via PHOSPHO1 Inhibition.” Acta Pharmaceutica Sinica B, vol. 14, no. 4, Apr. 2024, pp. 1711–25. EBSCOhost, https://doi.org/10.1016/j.apsb.2024.01.001.

APA

Yingting Wu, Jiaqi Xin, Xinyu Li, Ting Yang, Yi Liu, Yongsheng Zhao, Wen Xie, & Mengxi Jiang. (2024). Repurposing lansoprazole to alleviate metabolic syndrome via PHOSPHO1 inhibition. Acta Pharmaceutica Sinica B, 14(4), 1711–1725. https://doi.org/10.1016/j.apsb.2024.01.001

Chicago

Yingting Wu, Jiaqi Xin, Xinyu Li, Ting Yang, Yi Liu, Yongsheng Zhao, Wen Xie, and Mengxi Jiang. 2024. “Repurposing Lansoprazole to Alleviate Metabolic Syndrome via PHOSPHO1 Inhibition.” Acta Pharmaceutica Sinica B 14 (4): 1711–25. doi:10.1016/j.apsb.2024.01.001.